Loading...
Lifecore Biomedical Community
NasdaqGS:LFCR Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
Community Investing Ideas
Biopharma Partnerships And Injectable Demand Will Expand Global Reach
Key Takeaways Expanding partnerships, operational enhancements, and regulatory credibility are driving Lifecore's momentum in biopharma manufacturing, supporting stronger contract wins and profitability. Rising demand for injectable and HA-based drugs, along with new market entries, is broadening Lifecore's addressable market and cementing a foundation for sustained growth.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$8.75
n/aintrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
6.52% p.a.
Profit Margin
15.66%
Future PE
17.56x
Share price in 2028
US$11.1
